0001209191-23-006351.txt : 20230202
0001209191-23-006351.hdr.sgml : 20230202
20230202180747
ACCESSION NUMBER: 0001209191-23-006351
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230201
FILED AS OF DATE: 20230202
DATE AS OF CHANGE: 20230202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LYONS GARY A
CENTRAL INDEX KEY: 0001123343
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36620
FILM NUMBER: 23582708
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL
STREET 2: C/O NEUROCRINE BIOSCIENCES
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eledon Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001404281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 949-238-8090
MAIL ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
FORMER COMPANY:
FORMER CONFORMED NAME: Novus Therapeutics, Inc.
DATE OF NAME CHANGE: 20170511
FORMER COMPANY:
FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070622
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-01
0
0001404281
Eledon Pharmaceuticals, Inc.
ELDN
0001123343
LYONS GARY A
C/O ELEDON PHARMACEUTICALS, INC.
19900 MACARTHUR BLVD STE. 550
IRVINE
CA
92612
1
0
0
0
Stock Option (right to buy)
3.08
2023-02-01
4
A
0
20000
0.00
A
2033-02-01
Common Stock
20000
20000
D
This option represents a right to purchase up to 20,000 shares of Common Stock, which option vests with respect to 100% of the total number of shares on 2/1/2024.
/s/ Gary A. Lyons
2023-02-02